Clinical Trials Browser

Phase 1/2 × Thoracic Neoplasms × atezolizumab × Clear all

NCT07407933 2026-04-09

A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Lung Diseases, Thoracic Neoplasms, Small Cell Lung Carcinoma